Review finds TPP a threat to public health
A UNSW review of the proposed Trans Pacific Partnership (TPP) Agreement has found potential economic gains may come at a cost to Australians' health.
A UNSW review of the proposed Trans Pacific Partnership (TPP) Agreement has found potential economic gains may come at a cost to Australians' health.
A review of the proposed Trans Pacific Partnership (TPP) Agreement by researchers from UNSW, Sydney University and La Trobe has found potential economic gains may come at a cost to the health of Australians, particularly vulnerable populations.
Associate Professor Lynn Kemp, Director of UNSW’s Centre for Health Equity Training, Research and Evaluation, says their review looked at the potential impact of the TPP’s provisions on the cost of medicines, food labelling, tobacco and alcohol control policies.
“If this agreement is signed it may take longer for generic brand drugs to enter the market, which will increase the cost of the Pharmaceutical Benefits Scheme or hit consumers with higher out of pocket costs,” she says.
“People, particularly those from low socioeconomic backgrounds, will then face the choice of prioritising necessities like food and housing over purchasing prescription medicines to look after their health.”
The health impact assessment (HIA) also found the TPP’s current provisions:
Associate Professor Kemp says her biggest concern about the agreement is that it is being negotiated in secret.
“We call on the Government to conduct these trade negotiations with full public transparency,” she says.
“This is a complex issue, and what might be the right thing in terms of economics may not be appropriate for protecting public health in Australia.”
“Public health concerns must override economic or trade concerns in any area where these priorities may conflict within the TPP.”
The HIA makes a number of other recommendations including:
A copy of the HIA can be found here.
Media contact: Dan Wheelahan, UNSW Media Office, 0435 930 465, d.wheelahan@unsw.edu.au